209 related articles for article (PubMed ID: 18548509)
1. Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats.
Fuksa L; Brcakova E; Cermanova J; Hroch M; Chladek J; Kolouchova G; Malakova J; Martinkova J; Staud F; Micuda S
Biopharm Drug Dispos; 2008 Jul; 29(5):289-99. PubMed ID: 18548509
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
Bremnes RM; Slørdal L; Wist E; Aarbakke J
Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
[TBL] [Abstract][Full Text] [Related]
3. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats.
Fuksa L; Brcakova E; Kolouchova G; Hirsova P; Hroch M; Cermanova J; Staud F; Micuda S
Toxicology; 2010 Jan; 267(1-3):165-71. PubMed ID: 19922765
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats.
Park JM; Moon CH; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):353-62. PubMed ID: 8896046
[TBL] [Abstract][Full Text] [Related]
6. Enhanced systemic availability of methotrexate in the presence of morin in rats.
Hong SS; Jin MJ; Han HK
Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of low-dose methotrexate in adult asthmatics.
Glynn-Barnhart AM; Erzurum SC; Leff JA; Martin RJ; Cochran JE; Cott GR; Szefler SJ
Pharmacotherapy; 1992; 12(5):383-90. PubMed ID: 1437699
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
Joerger M; Huitema AD; van den Bongard HJ; Baas P; Schornagel JH; Schellens JH; Beijnen JH
Br J Clin Pharmacol; 2006 Jul; 62(1):71-80. PubMed ID: 16842380
[TBL] [Abstract][Full Text] [Related]
9. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
Kremer JM; Hamilton RA
J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
[TBL] [Abstract][Full Text] [Related]
11. Effect of folinic acid on tissue residence and excretion of methotrexate in rats.
He YL; Tanigawara Y; Yasuhara M; Hori R
Drug Metab Dispos; 1991; 19(4):729-34. PubMed ID: 1680647
[TBL] [Abstract][Full Text] [Related]
12. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
Statkevich P; Fournier DJ; Sweeney KR
J Pharmacol Exp Ther; 1993 Jun; 265(3):1118-24. PubMed ID: 8509997
[TBL] [Abstract][Full Text] [Related]
13. Clearance studies of methotrexate in dogs after multiple-rate infusion.
Lui CY; Lee MG; Chiou WL
Cancer Res; 1985 Apr; 45(4):1545-8. PubMed ID: 3978622
[TBL] [Abstract][Full Text] [Related]
14. Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate.
Najjar TA; Abou-Auda HS; Ghilzai NM
Cancer Chemother Pharmacol; 1998; 42(5):423-8. PubMed ID: 9771959
[TBL] [Abstract][Full Text] [Related]
15. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
Bremnes RM; Slørdal L; Wist E; Aarbakke J
Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
[TBL] [Abstract][Full Text] [Related]
16. Late-onset delayed excretion of methotrexate.
Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of methotrexate in the guinea pig.
Schlatter J; Di Blasi-Bouvet S; Raynaud F; Cisternino S
Cell Mol Biol (Noisy-le-grand); 1999 May; 45(3):363-8. PubMed ID: 10386793
[TBL] [Abstract][Full Text] [Related]
18. Metabolic interaction between methotrexate and 4'-(9-acridinylamino)methanesulfon-M-anisidide in the rabbit.
Lee YJ; Chan KK
Cancer Res; 1988 Sep; 48(18):5106-11. PubMed ID: 3409236
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
[TBL] [Abstract][Full Text] [Related]
20. Effect of nutritional status on the hepatobiliary excretion of methotrexate in the rat.
Grossie VB; Loo TL
Cancer Treat Rep; 1983 Mar; 67(3):253-7. PubMed ID: 6403239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
